Cell trafficking, mediator release, and articular metabolism in acute inflammation of innervated or denervated isolated equine joints

American Journal of Veterinary Research

Volumn 59, Issue 1, 1998, Pages 88-100

  Hardy, Joanne ^a   Bertone, Alicia L ^a   Weisbrode, Steven E ^a   Muir, William W ^a   O'Dorisio, Thomas M ^a   Masty, Jerome ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOLASE; INTERLEUKIN 1; INTERLEUKIN 6; PROSTAGLANDIN E2; SUBSTANCE P;

ANIMAL; ARTICLE; ARTICULAR CARTILAGE; BLOOD PRESSURE; DENERVATION; DRUG EFFECT; FEMALE; HORSE; IMMUNOLOGY; INFLAMMATION; INNERVATION; INSTRUMENTATION; JOINT; MALE; METHODOLOGY; NEUTROPHIL; ORCHIECTOMY; PATHOPHYSIOLOGY; PERFUSION; PHYSIOLOGY; SYNOVIAL FLUID; SYNOVIUM;

ANIMALS; BLOOD PRESSURE; CARTILAGE, ARTICULAR; DENERVATION; DINOPROSTONE; FEMALE; HORSES; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; JOINTS; MALE; NEUTROPHILS; ORCHIECTOMY; PERFUSION; PHOSPHOPYRUVATE HYDRATASE; SUBSTANCE P; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 0031613663     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. McIlwraith C. Diseases of joints, tendons and related structures. In: Stashak TS, ed. Adam's lameness in horses. Philadelphia: Lea & Febiger, 1987;339-485.
2. Todhunter RJ, Lust G. Pathophysiology of synovitis: clinical signs and examination in horses. Compend Contin Educ Pract Vet 1990;12:980-987.
3. May SA, Hooke RE, Lees P. Interleukin-1 stimulation of equine articular cells. Res Vet Sci 1992;52:342-348.
4. Baratz ME, Georgescu HI, Evans CH. Studies on the autocrine activation of a synovial cell line. J Orthop Res 1991;9:651-657.
5. Palmer JL, Bertone AL. Experimentally-induced synovitis as a model for acute synovitis in the horse. Equine Vet J 1994;26: 492-495.
6. Owens JG, Kamerling SG, Stanton SR, et al. Effect of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses. Am J Vet Res 1996;57:866-874.
7. Peloso JG, Stick JA, Caron JP, et al. Effects of hylan on amphotericin-induced carpal lameness in equids. Am J Vet Res 1993; 54:1527-1534.
8. Bertone AL, McIlwraith CW, Jones RL, et al. Comparison of various treatments for experimentally induced equine infectious arthritis. Am J Vet Res 1987;48:519-529.
9. Levine JD, Clark R, Devor M, et al. Intraneuronal substance P contributes to the severity of experimental arthritis. Science 1984;226:547-549.
10. Levine JD, Moskowitz MA, Basbaum AI. The contribution of neurogenic inflammation in experimental arthritis. J Immunol 1985;135:843-847.
11. Levine JD, Collier DH, Basbaum AI, et al. Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis. J Rheumatol 1985;12:406-411.
12. Levick JR. Blood flow and mass transport in synovial joints. The cardiovascular system IV: the microcirculation. In: Renkin EM, Michel CC, eds. Handbook of physiology. Bethesda, Md: American Physiological Society, 1984;917-994.
13. Colpaert FC, Donnerer J, Lembeck F. Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritis. Life Sci 1983;32:1827-1834.
14. Caron JP, Bowker RM, Abhold RH, et al. Substance P in the synovial membrane and fluid of the equine middle carpal joint. Equine Vet J 1992;24:364-366.
15. Bowker RM, Abhold RH, Caron JP, et al. Neuropeptidergic innervation of equine synovial joints. Am J Vet Res 1993;54:1831-1839.
16. Nixon AJ, Cummings JF. Substance P immunohistochemical study of the sensory innervation of normal subchondral bone in the equine metacarpophalangeal joint. Am J Vet Res 1994;55:28-33.
17. O'Byrne EM, Blancuzzi V, Wilson DE, et al. Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor. Arthritis Rheum 1990;33:1023-1028.
18. Muir WW, Skarda RT, Milne DW. Estimation of cardiac output in the horse by thermodilution techniques. Am J Vet Res 1976;37:697-700.
19. Allen D, Korthuis RJ, Clark S. Evaluation of Starling forces in the equine digit. J Appl Physiol 1988;64:1580-1583.
20. Bitter T, Muir H. A modified uronic acid carbazole reaction. Anal Biochem 1962;4:330-334.
21. Alwan WH, Carter SD, Bennett D, et al. Glycosaminoglycans in horses with osteoarthritis. Equine Vet J 1991;23:44-47.
22. Farndale RW, Sayers CA, Barrett AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage culture. Connect Tissue Res 1982;9:247-248.
23. McDonald MH, Stover SM, Willits NH, et al. Regulation of matrix metabolism in equine cartilage explant cultures by interleukin 1. Am J Vet Res 1992;53:2278-2285.
24. Daniels WW. Analysis of variance. In: WDW, ed. Biostatistics: a foundation for analysis in the health sciences. 5th ed. New York: John Wiley & Sons, 1991.
25. Bland JM, Altman DG. Statistical method for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
26. Van Pelt W. Interpretation of synovial fluid findings in the horse. J Am Vet Med Assoc 1974;165:91-95.
27. Bertone AL, Palmer JL, Jones J. Synovial fluid inflammatory mediators as markers of equine synovitis. Vet Surg 1993;22:372.
28. Miao FJ-P, Janig W, Levine JD. Role of sympathetic post-ganglionic neurons in synovial plasma extravasation induced by bradykinin. J Neurophysiol 1996;75:715-724.
29. Guerne P-A, Zuraw BL, Vaughan JH, et al. Synovium as a source of interleukin 6 in vitro. J Clin Invest 1989;83:582-592
30. Shinmei M, Masuda K, Kikuchi T, et al. The role of cytokines in chondrocyte mediated cartilage degradation. J Rheumat 1989;Suppl 18:32-34.
31. Blackburn WDJ, Heck L, Loose LD. Inhibitions of 5-lipoxygenase product formation and polymorphonuclear cell degranulation by tenidap sodium in patients with rheumatoid arthritis. Arhtritis Rheum 1991;34:204-210.
32. 2 concentration in synovial fluid of horses affected with arthropathy. Clin Vet 1980;103:544-549.
33. May SA, Hooke RE, Lees P. Identity of the E-series prostaglandin produced by equine chondrocytes and synovial cells in response to a variety of stimuli. Res Vet Sci 1989;46:54-57.
34. Fairburn K, Kunaver M, Wilkinson LS, et al. Intercellular adhesion molecules in normal synovium. Br J Rheumatol 1993;32: 302-306.
35. Morris EA, Treadwell BV. Effect of interleukin 1 on articular cartilage from young and aged horses and comparison with metabolism of osteoarthritic cartilage. Am J Vet Res 1994;55:138-146.
36. Alwan WH, Carter SD, Dixon JB, et al. Interleukin-1-like activity in synovial fluids and sera of horses with arthritis. Res Vet Sci 1991;51:72-77.
37. Morris EA, McDonald BS, Webb AC, et al. Identification of interleukin-1 in equine osteoarthritic joint effusions. Am J Vet Res 1990;51:59-64.
38. May SA, Hooke RE, Lees P. Species restriction demonstrated by the stimulation of equine cells with recombinant human interleukin-1. Vet Immunol Immunopathol 1992;30:373-384.
39. Henderson B, Pettipher ER. Comparison of the in vivo inflammatory activities after intraarticular injection of natural and recombinant IL-1 alpha and IL-1 beta in the rabbit. Biochem Pharm 1988;37:4171-4176.
40. May SA, Hooke RE, Lees P. The characterisation of equine interleukin-1. Vet Immunol Immunopathol 1990;24:169-175.
41. 4) using an enzyme-linked immunosorbent assay (ELISA) in horse plasma and synovial fluid. Toxicologist 1993;13:147.